Summary
Updated Aug 31, 2026
Tactic Pharma LLC is 10% Owner of Monopar Therapeutics (MNPR). 2 SEC Form 4 filings on record, most recently on 24 September 2025. Most recent open-market trade: sold $35.00M of MNPR on 24 September 2025. Lifetime open-market sales: $36.17M.
Recent Transactions
2Every recent SEC Form 4 transaction Tactic Pharma LLC has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Tactic Pharma LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kim R. Tsuchimoto - $911K of MNPR open-market activity in the last 12 months
- Raymond Anderson - $703K of MNPR open-market activity in the last 12 months
- Patrice Rioux - $111 of MNPR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Tactic Pharma LLC?
Tactic Pharma LLC is a corporate entity, tracked as 10% Owner of Monopar Therapeutics (MNPR). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Tactic Pharma LLC last file a Form 4?
The most recent primary Form 4 on record is dated 24 September 2025, one of 2 filings going back to 2025.
Has Tactic Pharma LLC been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($36.17M) across all tracked filings.
Where can I see all of Tactic Pharma LLC's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Tactic Pharma LLC and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
